TipRanks
Advertisement
Advertisement

DE:C6K0 Stock Latest News

Avalo Therapeutics price target lowered to $48 from $50 at Guggenheim
The FlyAvalo Therapeutics price target lowered to $48 from $50 at Guggenheim
2M ago
AVTX
Avalo Therapeutics price target lowered to $30 from $35 at H.C. Wainwright
PremiumThe Fly
Avalo Therapeutics price target lowered to $30 from $35 at H.C. Wainwright
2M ago
AVTX
Avalo Therapeutics reports Q2 EPS (83c), consensus (62c)
PremiumThe Fly
Avalo Therapeutics reports Q2 EPS (83c), consensus (62c)
2M ago
AVTX
Avalo Therapeutics files to sell 128,189 shares of common stock for holders
PremiumThe Fly
Avalo Therapeutics files to sell 128,189 shares of common stock for holders
3M ago
AVTX
Avalo Therapeutics initiated with an Outperform at Leerink
PremiumThe Fly
Avalo Therapeutics initiated with an Outperform at Leerink
3M ago
AVTX
Avalo Therapeutics to join Russell 2000, Russell 3000
PremiumThe FlyAvalo Therapeutics to join Russell 2000, Russell 3000
4M ago
AVTX
Avalo Therapeutics Adds Independent Director Ron Philip
Premium
Company Announcements
Avalo Therapeutics Adds Independent Director Ron Philip
4M ago
8K
AVTX
Avalo Therapeutics Expands Pipeline With New IL-1β Antibody
Premium
Company Announcements
Avalo Therapeutics Expands Pipeline With New IL-1β Antibody
4M ago
8K
AVTX
Avalo Therapeutics advances AVTX-010
PremiumThe Fly
Avalo Therapeutics advances AVTX-010
4M ago
AVTX
Avalo Therapeutics Expands Ownership Limits, Updates Executive Contracts
PremiumCompany Announcements
Avalo Therapeutics Expands Ownership Limits, Updates Executive Contracts
4M ago
8K
AVTX
Avalo Therapeutics initiated with a Buy at BofA
PremiumThe Fly
Avalo Therapeutics initiated with a Buy at BofA
4M ago
AVTX
Avalo Therapeutics Shareholders Back Directors and Governance Changes
PremiumCompany Announcements
Avalo Therapeutics Shareholders Back Directors and Governance Changes
4M ago
8K
AVTX
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
5M ago
ASPI
AVTX
Avalo Therapeutics price target lowered to $34 from $40 at Wedbush
Premium
The Fly
Avalo Therapeutics price target lowered to $34 from $40 at Wedbush
5M ago
AVTX
Avalo Therapeutics price target raised to $45 from $39 at Mizuho
Premium
The Fly
Avalo Therapeutics price target raised to $45 from $39 at Mizuho
5M ago
AVTX
Avalo Therapeutics price target lowered to $35 from $40 at H.C. Wainwright
PremiumThe Fly
Avalo Therapeutics price target lowered to $35 from $40 at H.C. Wainwright
5M ago
AVTX
Avalo Therapeutics price target lowered to $55 from $62 at Citizens
PremiumThe Fly
Avalo Therapeutics price target lowered to $55 from $62 at Citizens
5M ago
AVTX
Avalo Therapeutics Urges Investors to Heed Form 10-Q Risk Factors Amid Ongoing Uncertainty
PremiumCompany Announcements
Avalo Therapeutics Urges Investors to Heed Form 10-Q Risk Factors Amid Ongoing Uncertainty
5M ago
AVTX
Avalo Therapeutics reports Q1 EPS (98c), consensus ($1.01)
PremiumThe Fly
Avalo Therapeutics reports Q1 EPS (98c), consensus ($1.01)
5M ago
AVTX
Avalo Therapeutics price target raised to $60 from $48 at Piper Sandler
PremiumThe FlyAvalo Therapeutics price target raised to $60 from $48 at Piper Sandler
5M ago
AVTX
Avalo Therapeutics Announces Major Equity and Warrant Offering
Premium
Company Announcements
Avalo Therapeutics Announces Major Equity and Warrant Offering
5M ago
8K
AVTX
Avalo Therapeutics price target raised to $62 from $52 at Citizens
Premium
The Fly
Avalo Therapeutics price target raised to $62 from $52 at Citizens
5M ago
AVTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >